Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Gritstone bio Inc GRTSQ

Healthcare Biotechnology
Gritstone bio, Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers next generation cancer and infectious disease immunotherapy candidates. It has developed two vectors that it deploys with the aim of eliciting the desired immune response: self-amplifying mRNA (samRNA) and chimpanzee adenovirus (ChAd). Its two oncology programs in clinical-stage... see more

Recent & Breaking News (PINL:GRTSQ)

Gritstone Announces Changes to Its Board of Directors

GlobeNewswire June 1, 2021

Gritstone Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire May 24, 2021

Gritstone Reports First Quarter 2021 Financial Results and Business Highlights

GlobeNewswire May 6, 2021

Gritstone Oncology Changes its Name to Gritstone bio to Reflect Expanded Therapeutic Focus

GlobeNewswire May 3, 2021

Gritstone Announces First Person Dosed with its Second-Generation COVID-19 Vaccine in Phase 1 Study Conducted and Supported by NIAID/IDCRC

GlobeNewswire March 29, 2021

Gritstone Reports Fourth Quarter and Full Year 2020 Financial Results and Business Highlights

GlobeNewswire March 11, 2021

Gritstone Announces Promotions Within its Leadership Team

GlobeNewswire March 8, 2021

Gritstone to Present at the H.C. Wainwright Global Life Sciences Conference

GlobeNewswire March 2, 2021

Gilead Sciences and Gritstone Announce Collaboration Utilizing Gritstone's Vaccine Platform Technology for HIV Cure

Business Wire February 1, 2021

Gritstone and Genevant Sciences Announce License Agreement for COVID-19 Vaccine

GlobeNewswire January 20, 2021

Gritstone Advances Second Generation COVID-19 Vaccine "CORAL" Program with Support from NIAID; Program has Potential to Protect Against Mutant Variants of SARS-CoV-2

GlobeNewswire January 19, 2021

Gritstone Oncology to Present at the 39th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 11, 2021

Gritstone Oncology Announces Private Placement Financings Totaling $125 Million

GlobeNewswire December 28, 2020

Gritstone Oncology Announces $110 Million Private Placement

GlobeNewswire December 23, 2020

Gritstone Oncology Reports Third Quarter Financial Results and Recent Highlights

GlobeNewswire November 5, 2020

Gritstone Oncology Advances into Phase 2 Expansion Cohorts for its Personalized Neoantigen Immunotherapy GRANITE and its Off-the-Shelf Neoantigen Immunotherapy SLATE

GlobeNewswire November 2, 2020

Gritstone Oncology Announces Updated Presentation Time at Cantor Virtual Global Healthcare Conference

GlobeNewswire September 15, 2020

Gritstone Oncology to Webcast Presentations from Two Upcoming Investor Conferences in September

GlobeNewswire September 8, 2020

Gritstone Oncology Reports Second Quarter Financial Results and Recent Highlights

GlobeNewswire August 5, 2020

Gritstone Oncology to Present at Two Upcoming Investor Conferences in August

GlobeNewswire August 3, 2020